|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01358 PW MEDTECH
Nominal 
1.130 +0.030 (+2.727%) | 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Turnover | 823,505 | 7.101% | 768,903 | 675,084 | 536,826 | 271,399 |
| Cost of Sales | (416,046) | 19.056% | (349,455) | (294,187) | (238,001) | (105,343) |
| Gross Profit | 407,459 | -2.858% | 419,448 | 380,897 | 298,825 | 166,056 |
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | (1,820) | 53.976% | (1,182) | (61) | (250) | (52,591) | |
| Change in FV & Impairment on Others | (1,220) | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | (6,100) | -- | 731,750 | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 164,994 | -28.186% | 229,753 | 231,067 | 157,747 | 737,464 | |
| Taxation | (29,741) | -20.118% | (37,231) | (26,044) | (28,880) | 1,653 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (40,879) | -2.067% | (41,742) | (51,839) | (22,826) | 3 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 94,374 | -37.409% | 150,780 | 153,184 | 106,041 | 739,120 | |
| 2025/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (42,694) | -15.074% | (50,272) | (43,671) | (34,904) | (56,730) |
| Depreciation & Amortisation | 139,858 | 18.779% | 117,746 | 98,261 | 78,586 | 31,415 |
| Directors' Emoluments | 2,219 | 0.090% | 2,217 | 2,205 | 2,127 | 3,861 |
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | 6.250 | -36.029% | 9.770 | 9.780 | 6.770 | 47.100 |
| DPS (cts) | 5.624 | -- | 9.051 | 8.933 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | 89.985% | -- | 92.637% | 91.336% | -- | -- |
| Cash flow per share ($) | -- | -- | 0.206 | 0.135 | 0.172 | 0.024 |
| NBV per share ($) | 2.681 | -- | 2.671 | 2.583 | 2.520 | 2.417 |
| Remarks: | Real time quote last updated: 10/04/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 94,374 |
| %Change | -37.409% |
| EPS / (LPS) | RMB 0.063 |
| NBV Per Share (¥) | RMB 2.681 |